![]() | Up a level |
Jimenez-Pascual, Ana, Mitchell, Kelly, Siebzehnrubl, Florian A. and Lathia, Justin D.
2020.
FGF2: a novel druggable target for glioblastoma?
Expert Opinion on Therapeutic Targets
24
(4)
, pp. 311-318.
10.1080/14728222.2020.1736558
Item availability restricted. |
![]() |
Jimenez-Pascual, Ana, Hale, James S., Kordowski, Anja, Pugh, Jamie, Silver, Daniel J., Bayik, Defne, Roversi, Gustavo, Alban, Tyler J., Rao, Shilpa, Chen, Rui, McIntyre, Thomas M., Colombo, Giorgio, Taraboletti, Giulia, Holmberg, Karl O., Forsberg-Nilsson, Karin, Lathia, Justin D. and Siebzehnrubl, Florian A.
2019.
ADAMDEC1 maintains a growth factor signaling loop in cancer stem cells.
Cancer Discovery
9
(11)
, pp. 1574-1589.
10.1158/2159-8290.CD-18-1308
![]() |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Jimenez-Pascual, Ana, Lathia, Justin D. and Siebzehnrubl, Florian A. 2019. ADAMDEC1 and FGF2/FGFR1 signaling constitute a positive feedback loop to maintain GBM cancer stem cells. Molecular & Cellular Oncology 7 (1) , 1684787. 10.1080/23723556.2019.1684787 |
|
Jimenez-Pascual, Ana and Siebzehnrubl, Florian A
2019.
Fibroblast growth factor receptor functions in glioblastoma.
Cells
8
(7)
, 715.
10.3390/cells8070715
![]() |
![]() |
Jimenez-Pascual, Ana
2019.
Microenvironmental FGF2 regulates
glioblastoma stem cells through FGFR1-
ERK1/2-ZEB1 axis.
PhD Thesis,
Cardiff University.
Item availability restricted. |
![]() |
Hoang-Minh, Lan B., Siebzehnrubl, Florian A., Yang, Changlin, Suzuki-Hatano, Silveli, Dajac, Kyle, Loche, Tyler, Andrews, Nicholas, Massari, Michael Schmoll, Patel, Jaimin, Amin, Krisha, Vuong, Alvin, Jimenez Pascual, Ana, Kubilis, Paul, Garrett, Timothy J., Moneypenny, Craig, Pacak, Christina A., Huang, Jianping, Sayour, Elias J., Mitchell, Duane A., Sarkisian, Matthew R., Reynolds, Brent . and Deleyrolle, Loic P.
2018.
Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma.
EMBO Journal
37
(23)
, e98772.
10.15252/embj.201798772
![]() |
|